Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 4, 2006, Pages 1298-1303

  LaPlante, Kerry L ^a,c   Rybak, Michael J ^a,b   Leuthner, Kimberly D ^a   Chin, Judy N ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; DAPTOMYCIN; HABEKACIN; LINEZOLID; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG HALF LIFE; ENTEROCOCCUS FAECALIS; EXPERIMENTAL MODEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; POLYMICROBIAL INFECTION; PRIORITY JOURNAL; SIMULATION;

ACETAMIDES; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DIBEKACIN; ENTEROCOCCUS FAECALIS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; OXAZOLIDINONES; STAPHYLOCOCCUS AUREUS;

EID: 33645796448     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.4.1298-1303.2006     Document Type: Article

References (17)

1. Andes, D., M. L. van Ogtrop, J. Peng, and W. A. Craig. 2002. In vivo pharmacodynamics of a new oxazolidinone (Hnezolid). Antimicrob. Agents Chemother. 46:3484-3489.
2. Barry, A. L., P. C. Fuchs, and S. D. Brown. 2001. In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob. Agents Chemother. 45:1919-1922.
3. Cleveland, J., T. J. Montville, I. F. Nes, and M. L. Chikindas. 2001. Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 71:1-20.
4. Giraffa, G. 2003. Functionality of enterococci in dairy products. Int. J. Food Microbiol. 88:215-222.
5. 2+ and albumin on these drugs. Antimicrob. Agents Chemother. 35:1710-1716.
6. LaPlante, K. L., and M. J. Rybak, 2004. Clinical glycopeptide- intennediate staphylococci tested against arbekacin, daptomycin, and tigecycline. Diagn. Microbiol. Infect. Dis. 50:125-130.
7. LaPlante, K. L., and M. J. Rybak. 2004. Impact of high-inoculum Staphyloccus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model Antimicrob. Agents Chemother. 48:4665-4672.
8. Mantey, I., R. L. Hill, A. V. Foster, S. Wilson, J. J. Wade, and M. E. Edmonds. 2000. Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients. Commun. Dis. Public Health 3:288-290.
9. Moise-Broder, P. A., G. Sakoulas, G. M. Eliopoulos, J. J. Schentag, A. Forrest, and R. C. Moellering, Jr. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38:1700-1705.
10. National Committee for Clinical Laboratory Standards. 2003. Approved standard M7-A6. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. National Committee for Clinical Laboratory Standards. 2003. MIC testing supplemental tables. M100-S13. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Navarro, L., M. Zarazaga, J. Saenz, F. Ruiz-Larrea, and C. Torres. 2000. Bacteriocin production by lactic acid bacteria isolated from Rioja red wines. J. Appl. Microbiol. 88:44-51.
13. Rocba, H., M. Barros, and M. Magnavita. 1965. [Clinical study of mixed infections of the urinary tract.] Hospital (Rio de Janeiro) 67:789-793.
14. Tenover, F. C., L. M. Weigel, P. C Appelbaum, L. K. McDougal, J. Chaitram, S. McAllister, N. Clark, G. Killgore, C. M. O'Hara, L. Jevitt, J. B. Patel, and B. Bozdogan. 2004. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob. Agents Chemother. 48:275-280.
15. Wise, R., J. M. Andrews, and J. P. Ashby. 2001. Activity of daptomycin against gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint. J. Antimicrob. Chemother. 48:563-567.
16. Wise, R., T. Gee, J. M. Andrews, B. Dvorchik, and G. Marshall. 2002. Pharmacokinetics and inflammatory fluid penetration of intravenous daptomycin in volunteers. Antimicrob. Agents Chemother. 46:31-33.
17. Zhanel, G. G., K. Homenuik, K. Nichol, A. Noreddin, L. Vercaigne, J. Embil, A. Gin, J. A. Karlowsky, and D. J. Hoban. 2004. The glycylcyclines: a comparative review with the tetracyclines. Drugs 64:63-88.